Stryker argued that no ABG II lawsuits were included in the litigation and wanted cases involving the AGB II to be removed from the litigation. The JPML found that three Stryker ABG II implant lawsuits had been added to an amended motion and that the devices were similar enough to the Rejuvenate hip implant system to include them in the MDL. The JPML also denied Stryker's request to drop its name from the MDL because, according to the company's website, Stryker initiated the voluntary recall in 2012. While Stryker alleges that the recalled hip implants were manufactured and sold by Howmedica Osteonics Corporation, the JPML found that the Stryker name has been consistently used in all of the recall notices and other communications by the company. Therefore, it is appropriate for the Stryker name to be included in the MDL.